SG11201608624PA - Drug for treatment of tinnitus patients - Google Patents
Drug for treatment of tinnitus patientsInfo
- Publication number
- SG11201608624PA SG11201608624PA SG11201608624PA SG11201608624PA SG11201608624PA SG 11201608624P A SG11201608624P A SG 11201608624PA SG 11201608624P A SG11201608624P A SG 11201608624PA SG 11201608624P A SG11201608624P A SG 11201608624PA SG 11201608624P A SG11201608624P A SG 11201608624PA
- Authority
- SG
- Singapore
- Prior art keywords
- drug
- treatment
- tinnitus patients
- tinnitus
- patients
- Prior art date
Links
- 208000009205 Tinnitus Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 231100000886 tinnitus Toxicity 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014092867 | 2014-04-28 | ||
| PCT/JP2015/062711 WO2015166917A1 (en) | 2014-04-28 | 2015-04-27 | Drug for treatment of tinnitus patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201608624PA true SG11201608624PA (en) | 2016-11-29 |
Family
ID=54358644
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201608624PA SG11201608624PA (en) | 2014-04-28 | 2015-04-27 | Drug for treatment of tinnitus patients |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20170049717A1 (en) |
| EP (1) | EP3138559A4 (en) |
| JP (2) | JP5978471B2 (en) |
| KR (1) | KR20160143846A (en) |
| CN (1) | CN106413698A (en) |
| AU (1) | AU2015254240A1 (en) |
| BR (1) | BR112016024918A2 (en) |
| CA (1) | CA2946146A1 (en) |
| EA (1) | EA201692163A1 (en) |
| IL (1) | IL248252A0 (en) |
| MX (1) | MX2016014010A (en) |
| PH (1) | PH12016502113A1 (en) |
| SG (1) | SG11201608624PA (en) |
| WO (1) | WO2015166917A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2548552B1 (en) * | 2007-09-12 | 2015-11-18 | Merz Pharma GmbH & Co. KGaA | Titration package for 1-amino-alkylcyclohexanes |
| US20110294890A1 (en) * | 2010-05-28 | 2011-12-01 | Merz Pharma Gmbh & Co. Kgaa | Neramexane for the treatment or prevention of inner ear disorders |
| WO2012098000A1 (en) * | 2011-01-20 | 2012-07-26 | Merz Pharma Gmbh & Co. Kgaa | Neramexane for the treatment or prevention of tinnitus related with stress or acute hearing loss |
-
2015
- 2015-04-27 EP EP15785715.2A patent/EP3138559A4/en not_active Withdrawn
- 2015-04-27 WO PCT/JP2015/062711 patent/WO2015166917A1/en not_active Ceased
- 2015-04-27 BR BR112016024918A patent/BR112016024918A2/en not_active Application Discontinuation
- 2015-04-27 EA EA201692163A patent/EA201692163A1/en unknown
- 2015-04-27 US US15/306,258 patent/US20170049717A1/en not_active Abandoned
- 2015-04-27 KR KR1020167032220A patent/KR20160143846A/en not_active Withdrawn
- 2015-04-27 AU AU2015254240A patent/AU2015254240A1/en not_active Abandoned
- 2015-04-27 MX MX2016014010A patent/MX2016014010A/en unknown
- 2015-04-27 CA CA2946146A patent/CA2946146A1/en not_active Abandoned
- 2015-04-27 JP JP2015553333A patent/JP5978471B2/en not_active Expired - Fee Related
- 2015-04-27 SG SG11201608624PA patent/SG11201608624PA/en unknown
- 2015-04-27 CN CN201580023605.5A patent/CN106413698A/en active Pending
-
2016
- 2016-05-06 JP JP2016093336A patent/JP2016138144A/en active Pending
- 2016-10-09 IL IL248252A patent/IL248252A0/en unknown
- 2016-10-21 PH PH12016502113A patent/PH12016502113A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20170049717A1 (en) | 2017-02-23 |
| MX2016014010A (en) | 2017-01-11 |
| WO2015166917A1 (en) | 2015-11-05 |
| BR112016024918A2 (en) | 2017-08-15 |
| JP5978471B2 (en) | 2016-08-24 |
| IL248252A0 (en) | 2016-11-30 |
| CA2946146A1 (en) | 2015-11-05 |
| JPWO2015166917A1 (en) | 2017-04-20 |
| JP2016138144A (en) | 2016-08-04 |
| CN106413698A (en) | 2017-02-15 |
| EA201692163A1 (en) | 2017-03-31 |
| EP3138559A4 (en) | 2017-10-25 |
| EP3138559A1 (en) | 2017-03-08 |
| KR20160143846A (en) | 2016-12-14 |
| AU2015254240A1 (en) | 2016-11-10 |
| PH12016502113A1 (en) | 2017-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3212233T (en) | Combination therapy for treatment of disease | |
| IL252839A0 (en) | Treatment of pemphigus | |
| SMT201900176T1 (en) | Mrna therapy for the treatment of ocular diseases | |
| LT3097085T (en) | Benzoxazinone derivatives for treatment of skin diseases | |
| IL249502B (en) | Novel therapeutic uses of benzylideneguanidine derivatives for the treatment of proteopathies | |
| IL257355B (en) | Selection of patients for combination therapy | |
| SG11201608257RA (en) | A device for a medical treatment of a sclera | |
| ZA201705847B (en) | Treatment of pain | |
| GB201408387D0 (en) | Treatment of respiratory disorders | |
| HUE070257T2 (en) | Compounds for the treatment of lipofuscin related diseases | |
| SG11201704169WA (en) | Pharmaceutical composition for treatment or palliation of elderly or end-stage cancer patient | |
| GB201410407D0 (en) | Treatment of chagas disease | |
| IL250146A0 (en) | Methods for determining drug response of patient specific mutations | |
| HUE061056T2 (en) | Preparation for the treatment of infertility in female patients | |
| GB201412010D0 (en) | Treatment of hypertransaminasemia | |
| IL248253A0 (en) | Drug for treatment of tinnitus patients | |
| IL248252A0 (en) | Drug for treatment of tinnitus patients | |
| GB201501800D0 (en) | Treatment of medical conditions | |
| GB201621398D0 (en) | Treatment of emt-associated disease | |
| GB201504413D0 (en) | Treatment of disease | |
| GB201506944D0 (en) | Therapeutic treatment | |
| GB201406225D0 (en) | Treatment for respiratory disease |